Literature DB >> 33683487

Dysmobility syndrome: a case-series study describing a musculoskeletal syndrome in postmenopausal Mexican women.

Karen Burgueno-Aguilar1, Francisco Fidencio Cons-Molina2, Daniela Garcia-Jimenez2, Luis Eduardo Bejarano-Lopez3, Marissa Alexandra Gudino-Barroso4.   

Abstract

"Dysmobility Syndrome" (DS) is a term that correlates sarcopenia and osteoporosis together with mobility disturbances, obesity, fractures, and falls. The prevalence of DS is of 74% in this study. Further research with bigger sample sizes is needed to describe if prevalence and DS characteristics are similar in other studies.
PURPOSE: "Dysmobility Syndrome" (DS) correlates sarcopenia and osteoporosis together with mobility disturbances, obesity, fractures, and falls, all of which are related to adverse outcomes in the health of the elderly; however, there are no studies of DS in Mexican patients. In this study, we aimed to describe the characteristics of DS in Mexican postmenopausal women from a private practice.
METHODS: A case-series study was conducted; women of 60 years and older were invited to participate from August to December of 2019, a total of 50 patients were included. Medical history, physical tests, bone densitometry, and body composition analysis were performed; patients who met 3 or more of the following criteria were diagnosed with DS: osteoporosis: T-score ≤ -2.5, falls in a previous year, lean appendicular mass: ≤ 5.45 kg/m2, walking speed: < 1.0 m/s, grip strength: < 20 kg, and body fat percentage: > 40%.
RESULTS: Out of the total 50 patients, 37 were diagnosed with DS, with a prevalence of 74% in our study. Sixteen patients had a history of a non-vertebral fragility fracture, of which 14 had a diagnosis of DS (87%).
CONCLUSIONS: DS has a high frequency in our study group, and was found to be closely related to the presence of non-vertebral fragility fractures. More research is needed to describe the prevalence and characteristics of DS with a stronger statistical significance within our population, and among others across the country, to get an extensive understanding of its presentation in Mexican women. KEY POINTS: • The frequency of DS in this study is higher than the one that is described in global literature. • DS diagnosis is closely related to the antecedent of non-vertebral fragility fracture.

Entities:  

Keywords:  Dysmobility syndrome; Fragility fracture; Osteoporosis; Osteosarcopenia; Sarcopenia

Mesh:

Year:  2021        PMID: 33683487     DOI: 10.1007/s11657-021-00897-7

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  4 in total

1.  Dysmobility Syndrome Independently Increases Fracture Risk in the Osteoporotic Fractures in Men (MrOS) Prospective Cohort Study.

Authors:  Bjoern Buehring; Karen E Hansen; Brian L Lewis; Steven R Cummings; Nancy E Lane; Neil Binkley; Kristine E Ensrud; Peggy M Cawthon
Journal:  J Bone Miner Res       Date:  2018-06-21       Impact factor: 6.741

2.  Comparison of the prevalence of sarcopenia using skeletal muscle mass index and calf circumference applying the European consensus definition in elderly Mexican women.

Authors:  Maria Consuelo Velazquez-Alva; Maria Esther Irigoyen Camacho; Irina Lazarevich; Jaime Delgadillo Velazquez; Patricia Acosta Dominguez; Marco A Zepeda Zepeda
Journal:  Geriatr Gerontol Int       Date:  2015-11-04       Impact factor: 2.730

Review 3.  Dysmobility syndrome: current perspectives.

Authors:  Keith D Hill; Kaela Farrier; Melissa Russell; Elissa Burton
Journal:  Clin Interv Aging       Date:  2017-01-16       Impact factor: 4.458

4.  Exploring the link between metabolic syndrome and risk of dysmobility syndrome in elderly population.

Authors:  Yuan-Yuei Chen; Tung-Wei Kao; Chung-Ching Wang; Ying-Jen Chen; Chen-Jung Wu; Wei-Liang Chen
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

  4 in total
  1 in total

1.  The impact of sarcopenia on low back pain and quality of life in patients with osteoporosis.

Authors:  Shoji Iwahashi; Ryuki Hashida; Hiroo Matsuse; Eriko Higashi; Masafumi Bekki; Sohei Iwanaga; Koji Hara; Takahiko Higuchi; Yohei Hirakawa; Asami Kubota; Hiromi Imagawa; Yoko Muta; Kazuhito Minamitani; Tatsuhiro Yoshida; Kimiaki Yokosuka; Kei Yamada; Kimiaki Sato; Naoto Shiba
Journal:  BMC Musculoskelet Disord       Date:  2022-02-11       Impact factor: 2.362

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.